Vestal Point Capital, LP

13F Holdings History for Lexeo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (LXEO)

Symbol: LXEO on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 4.12M shares
Security Ownership: 7.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Vestal Point Capital, LP ownership in Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO)

2025-11-14 - Vestal Point Capital, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.12M shares of Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO). This represents 7.5% percent ownership of the company. In their previous filing dated 2025-08-14, Vestal Point Capital, LP had reported owning 3.23M shares, indicating an increase of 27.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Vestal Point Capital, LP	7.5%	+25%	$27.3M	4.12M	+889,141	+27.5%	$6.64	13G/A	9/30/2025	14 Nov 2025 16:00:23
Vestal Point Capital, LP	6%		$15.2M	3.23M			$4.72	13G	6/30/2025	14 Aug 2025 15:51:10

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.98%	+0.01%	$21.6M	3.25M	+21,839	+0.68%	$6.64	Q3 2025
6/30/2025	0.68%	+0.44%	$13M	3.23M	+2,091,912	+184%	$4.02	Q2 2025
3/31/2025	0.28%	-0.02%	$3.94M	1.14M	-63,751		$3.47	Q1 2025
12/31/2024	0.47%	+0.14%	$7.9M	1.2M	+350,000	+41.2%	$6.58	Q4 2024
9/30/2024	0.61%	+0.01%	$7.68M	850K	+10,000	+1.19%	$9.04	Q3 2024
6/30/2024	1%	+0.88%	$13.5M	840K	+665,000	+380%	$16.04	Q2 2024
3/31/2024	0.23%	+0.29%	$2.74M	175K	+175,000	NEW	$15.68	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.